Denali National Park is offering a one-year temporary trial for commercial dog sled trips, including guided passenger and sled-supported ski expeditions through December 2026.
Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle™ (TV)-enabled investigational therapy for Hunter syndrome Expecting multiple clinical data readouts ...
(RTTNews) - Denali Therapeutics Inc. (DNLI) says 2026 will be a defining year, as the company readies its first commercial product, Tividenofusp alfa, and advances a broad slate of clinical programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results